| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |